|
1 Jemal A, Bray F, Center MM. Global cancer statistics [ J]. CA Cancer J Clin,2011,49 (1):33-64.
|
|
2 National Cancer Institute. Surveillance, epidemiology and end results (SEER) cancer statistics review, 1975-2002 [EB/OL]. (2009-01-21) [2011-03-01] http://seer.cancer.gov/csr/1975_ 2002/.
|
|
3 Wan XL, Cai Q, Zhang J, et al. Prognostic factors of cervical cancer and the difficulties and progress of primary staging [J/CD]. Chin J Obstet Gynecol Pediatr (Electron Ed), 2008, 4(6): 59-62. [万晓丽，柴青，张建，等.影响宫颈癌预后的因素及现有临床分期的难点与进展[J/CD].中华妇幼临床医学杂志：电子版，2008，4 (6)：59-62.]
|
|
4 Agress H Jr, Wong TZ, Shreve P. Interpretation and reporting of positron emission tomography-computed tomographic scans [ J]. Semin Ultrasound CT MR,2008,29(4) :283-290.
|
|
5 Czernin J, Benz MR, Allen-Auerbach MS, et al. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination[J]. Eur J Radiol,2010,73(3) :470-480.
|
|
6 Wang JQ. The performance and application of 18F-FDG PET/CT in diagnosis of tumor [J]. Foreign Med Sci: Sect Radiat Med Nuclear Med,2004, 28(2):49-53.[王俊起.18F-FDG PET/CT的特点及其在肿瘤诊断中的应用[J].国外医学：放射医学核医学分册，2004,28(2)：49-53.]
|
|
7 Ng SH, Ko SF, Toh CH, et al. Imaging of neck metastases [J]. Chang Gung Med J, 2006, 29(2): 119-129.
|
|
8 Zheng H, Chen JZ, Luo RC, et al. The Value of 18F-FDG PET/ CT in the diagnosis and treatment of cervical cancer [J]. Pract J Cancer, 2009, 24(5):494-497.[郑航，陈锦章，罗荣城，等.18F FDG PET/CT显像对宫颈癌诊断及治疗的影响[J].实用癌症杂志，2009，24(5)：494-497.]
|
|
9 Groheux D, Hindie E, Baillet G, et al. Advantages of PET-CT in the work-up of cervical cancer[J]. Bull Cancer, 2009, 96 (2): 199-211.
|
|
10 Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: A prospective study [J]. Gynecol Oncol, 2007, 106(1) : 29-34.
|
|
11 Yildirim Y, Sehirali S, Avci ME, et al. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings[J]. Gynecol Oncol, 2008,108(1): 154-159.
|
|
12 Qui JT, Ho KC, Lai CH, et al. Supraclavicular lymph node metastases in cervical cancer[J]. Eur J Gynaecol Oncol,2007,28(1): 33-38.
|
|
13 Husain A, Akhurst T, Larson S, et al. A prospective study of the accuracy of 18 Fluorodeoxyglucose positron emission tomography (18 FDG PET) in identifying sites of metastasis prior to pelvic exenteration[J]. Gynecol Oncol, 2007, 106 (1) : 177-180.
|
|
14 Jover R, Lourido D,Gonzalez C, et al. Role of PET/CT in the evaluation of cervical cancer [J]. Gynecol Oncol, 2008, 110 (3):S55-S59.
|
|
15 Kitajima K, Murakami K, Yamasaki E, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: Comparison with PET and enhanced CT[J]. Eur J Nucl Med Mol Imag, 2009, 36(3): 362-372.
|
|
16 Wang JH, Yang JX, Shen K, et al. The role of PET scan in the detection of recurrent cervical cancer [ J]. Prog Obstet Gynecol, 2006,15 (12) :911-913. [王瑾晖，杨佳欣，沈铿，等. PET在监测宫颈癌复发中的应用 [J].现代妇产科进展，2006,15 (12)：911-913.]
|
|
17 Kitajima K, Murakami K, Yamasaki E. Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer[J]. Eur Radiol,2008,18(10):2040-2047.
|
|
18 Yen TC, See LC. Defining the priority of using 18 F-FDG PET for recurrent cervical cancer [J]. J Nucl Med, 2004, 45 (10): 1632-1639.
|
|
19 Jao MS, Chang TC, Chang HP, et al. Long-term follow up of cervical cancer patients with unexplained squamous cell carcinoma antigen elevation after post-therapy surveillance using positron emission tomography [J]. J Obstet Gynaecol Res, 2010, 36 (5): 1003-1008.
|
|
20 Grigsby PW. PET/CT imaging to guide cervical cancer therapy [J]. Future Oncol, 2009,5(7): 953-958.
|
|
21 Bjurberg M, Kjellén E, Ohlsson T, et al. FDG-PET in cervical cancer: Staging, restaging and follow-up[J]. Acta Obstet Gynecol Scand, 2007, 86:1384-1391.
|
|
22 Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT[J]. Radiology, 2006, 238(1):272-279.
|
|
23 Yen TC, See LC, Lai CH, et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression[J]. J Nucl Med, 2004, 45 (10): 22-29.
|
|
24 Ong LC, Jin Y, Song IC, et al. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II[J]. Acta Radiol, 2008, 49(10): 1145-1153.
|
|
25 Huang JM, Pan LP, Li DX. The application of PET and PET-CT in cervical cancer [J]. Int J Radiat Med Nucl Med, 2007,31(2):112-114.[黄建敏，潘莉萍，李冬雪. PET和PET-CT在宫颈癌中的应用价值[J].国际放射医学核医学杂志，2007，31(2) :112-114.]
|